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The MaineHealth Cancer 
Care Network (MHCCN) 
has received a $5.1 million 
award to increase access to 
cancer clinical trials in rural 
areas that will address ef-
forts to improve cancer pre-
vention, treatment and care 
delivery. Work under the 
grant will be led by Scot  
Remick, MD, Christopher 
Darus, MD, and Peter  
Rubin, MD. 
 
The six-year, $5.1 million 
award from the National 
Cancer Institute Communi-
ty Oncology Research Pro-
gram (NCORP) is the single 
largest grant ever extended 
by the National Cancer In-
stitute (NCI) for clinical 
cancer research and cancer 
clinical trials in the state of 
Maine.  
 
It will establish the Maine-
Health Cancer Care Net-
work Lifespan Program, 
designed to bring the latest 
research in cancer preven-
tion, cancer treatment and 
cancer care delivery to  
underserved populations.  
NCORP is funding a total 
of 46 institutions, 32 of 
which like the MHCCN are 
community-based sites. 
 
The MHCCN Lifespan Pro-
gram will be the only oncol-
ogy program in Northern 
New England to enroll pa-
tients in NCI clinical trials 
at every stage of the cancer 
continuum, from preven-
tion to survivorship.  
 
Some of the studies will fo-
cus on cancer control and 
prevention, with a goal of 
reducing the incidence, risk 
and mortality rates for can-
cer and improving quality of 
life for survivors. Others 
will aim to improve the way  
cancer care is delivered. 
 
“Patients often feel that in 
order to get state-of-the-art 
care and to enroll in clinical 
trials, they need to travel to 
a major metropolitan area,” 
said Dr. Remick, who is 
Maine Medical Center’s 
Chief of Oncology and the 
principal investigator of the 
Lifespan Program. “We be-
lieve patients should have 
access to advanced care 
close to home – wherever 
they live. This grant is a 
transformational award that 
will bring a wide variety of 
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Thank you for your support of the MaineHealth United 
Way Food Drive. Your donations are on their way to 
help our neighbors in need. 
 
The MaineHealth United Way Campaign begins Sept. 13. 
Employees should look for an email with their pledge 
link. 
 
Join us to kick off the United Way of Greater Portland 
Campaign and Sculpture Contest: 
 Friday, Sept. 13, Noon 
 Monument Square 
 Shuttle leaves Bramhall at 11:45 a.m., returning at  
      1 p.m. 
Thank You For Donating To the United Way Food Drive! 
Jessica J. Bian, MD, has 
recently joined Maine Medi-
cal Partners – Medical On-
cology in South Portland 
after completing a fellow-
ship in hematology/medical 
oncology at Brown  
University, Providence, 
Rhode Island.  
 
She earned her medical de-
gree at New York Universi-
ty School of Medicine, New 
York City, and completed 
her residency in internal 
medicine at Brown Univer-
sity. Her undergraduate de-
gree in molecular, cellular 
and developmental biology 
is from Yale University.  
She has a particular interest 
in the treatment of patients 
with lung cancer and head 
and neck cancer. 
 
Stephen Ryan, MD, has 
joined Maine Medical  
Partners – Surgical Care, in 
the Division of Urology.  
 
Dr. Ryan is an Urologist 
specializing in diagnosing 
and treating patients with 
prostate, kidney, bladder 
and testicular cancer. He 
has expertise in robotic, 
laparoscopic and open sur-
gery for the management of 
multiple genitourinary  
malignancies (adrenal, kid-
ney, ureter, retroperitoneal 
sarcoma, prostate, bladder, 
testicular and penile). 
 
He also provides care for 
other urologic conditions 
including benign prostatic 
hyperplasia (BPH) or en-
larged prostate, elevated 
prostate-specific antigen 
(PSA) levels and the pres-
ence of blood in urine 
(hematuria).  
 
He received his master’s in 
physiology from 
Georgetown University and 
his medical degree from 
East Carolina University 
School of Medicine in 
Greenville, North Carolina. 
He completed his residency 
in urology at Maine Medical 
Center.  
 
Dr. Ryan went on to com-
plete a fellowship in uro-
logic oncology in the De-
partment of Urology at the 
University of California in 
San Diego, California.  
 
His research interests in-
clude management of  
urologic cancer, improve-
ments on clinical outcomes, 
genetic markers of risk in 
cancer and clinical trials 
with neoadjuvant therapy.  
 
Micheal Hellen, MD, has 
joined Maine Medical Part-
ners – Hospital Medicine. 
Dr. Hellen will be working 
at both MMC and Stephens 
Memorial Hospital.  
 
A graduate of University of 
Nevada School of Medi-
cine, Dr. Hellen completed 
his residency here at Maine 
Medical Center.  
 
Dr. Hellen’s clinical inter-
ests include medical  





Patients currently have ac-
cess to clinical trials through 
the MHCCN at Maine 
Medical Center, Maine 
General Medical Center, 
Southern Maine Health 
Care, Stephens Memorial  
 
Hospital, Waldo County 
General Hospital and Pen 
Bay Medical Center. St. 
Mary’s Regional Medical 
Center and Mid Coast Hos-
pital are expected to begin 
enrolling cancer patients 
through the MHCCN early 
next year.  
 
 
The Lifespan Program will 
help extend the reach of 
clinical trials to Franklin 
Memorial Hospital, Lincoln 
Health and Memorial Hos-
pital in North Conway as 
well as increase the number 
of clinical trials available to 
patients at other locations 
within the MHCCN. The  
 
number of clinical trials 
available to oncology pa-
tients in the MHCCN is 
expected to nearly triple 
during the life of this grant. 
 
For more information on 
how you might be able to 
participate in a clinical trial, 
visit: mainehealth.org/cancer. 
